Dermatology Series

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

Dermatology Series

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

Dermatology Series

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

Dermatology Series

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

Dermatology Series

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond
Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

COVID-19 Webinar

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

  • Free

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Lilly, and UCB.

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

COVID-19 Webinar

Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond

  • Free

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Lilly, and UCB.

About this course

General

Skill level: All levels
Estimated time to complete activity: 1 Hour
Release date: April 16, 2020

Languages

English

Description

In this webinar, we review the use of biologics during COVID-19 in diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. Using a case-based approach, the discussions cover a summary of immunosuppressive actions for the different biologics, risk for use in infection, considerations when choosing between biologics, and accounting for a patient’s comorbidities.